Jj. Jager et al., Anti-apoptotic phenotype is associated with decreased locoregional recurrence rate in breast cancer, ANTICANC R, 20(2B), 2000, pp. 1269-1275
Purpose: Tumor stage and nodal status are the most important factors predic
ting locoregional recurrence in breast cancer We wanted to investigate the
prognostic value of some newer molecular genetic markers for the occurrence
of a locoregional recurrence in order to improve the selection of patients
for locoregional adjuvant therapy. Methods: Bcl-5 p53, MIB-1, pS2 and CD44
v6 were determined immunohistochemically on formalin fixed and paraffin emb
edded tumour tissues of 163 patients treated by modified radical mastectomy
between 1982 and 1987 Postoperative irradiation was given to 35 patients t
o the intermammary chain only and to only 13 (8%) patients to the chest wal
l with or without the regional lymph nodes. Node-positive patients were tre
ated with CAF adjuvant chemotherapy and were randomized for whether or no a
dditional Medroxyprogesteroneacetate (MPA). A multivariate analysis was per
formed on a number of potential prognostic factors. The risk for locoregion
al recurrence was estimated rising the competing risk approach. Results: Af
ter a median period of 7.5 years 28 patients developed a locoregional recur
rence. The cumulative incidence of loco-regional recurrence at 10 years was
17%. Bcl-2 and p53 were found to be independent factors predicting locoreg
ional recurrence whereas a trend was found for MIB-1. Increased Bcl-2 as we
ll as p53 expression were associated with a decreased risk, whereas the inc
reased presence of MIB-1 was associated with an increased risk. Conclusion:
Results indicate that molecular markers of apoptosis as well as proliferat
ion provide additional information for the risk of locoregional recurrence
after modified radical mastectomy. If confirmed these markers may play a ro
le in the selection of appropriate locoregional adjuvant treatment after pr
imary surgery.